抗凝固剤注射のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Anticoagulant Injections Market Insights, Forecast to 2028

• レポートコード：QY2207E10356 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の抗凝固剤注射の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗凝固剤注射の世界市場のxxx％を占める「LMWH」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「VTE」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の抗凝固剤注射の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの抗凝固剤注射市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの抗凝固剤注射市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 抗凝固剤注射のグローバル主要メーカーには、Sanofi、Genentech (Roche)、Boehringer Ingelheim、Aspen、Pfizer、Hepalink、King-friend、CSBIO、Amphastar Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 抗凝固剤注射市場は、種類と用途によって区分されます。世界の抗凝固剤注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 LMWH、未分画ヘパリン、線溶薬、その他 【用途別セグメント】 VTE、ACS/MI、AF、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 抗凝固剤注射製品概要 - 種類別市場（LMWH、未分画ヘパリン、線溶薬、その他） - 用途別市場（VTE、ACS/MI、AF、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の抗凝固剤注射販売量予測2017-2028 - 世界の抗凝固剤注射売上予測2017-2028 - 抗凝固剤注射の地域別販売量 - 抗凝固剤注射の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別抗凝固剤注射販売量 - 主要メーカー別抗凝固剤注射売上 - 主要メーカー別抗凝固剤注射価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（LMWH、未分画ヘパリン、線溶薬、その他） - 抗凝固剤注射の種類別販売量 - 抗凝固剤注射の種類別売上 - 抗凝固剤注射の種類別価格 ・用途別市場規模（VTE、ACS/MI、AF、その他） - 抗凝固剤注射の用途別販売量 - 抗凝固剤注射の用途別売上 - 抗凝固剤注射の用途別価格 ・北米市場 - 北米の抗凝固剤注射市場規模（種類別、用途別） - 主要国別の抗凝固剤注射市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの抗凝固剤注射市場規模（種類別、用途別） - 主要国別の抗凝固剤注射市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の抗凝固剤注射市場規模（種類別、用途別） - 主要国別の抗凝固剤注射市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の抗凝固剤注射市場規模（種類別、用途別） - 主要国別の抗凝固剤注射市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの抗凝固剤注射市場規模（種類別、用途別） - 主要国別の抗凝固剤注射市場規模（トルコ、サウジアラビア） ・企業情報 Sanofi、Genentech (Roche)、Boehringer Ingelheim、Aspen、Pfizer、Hepalink、King-friend、CSBIO、Amphastar Pharmaceuticals ・産業チェーン及び販売チャネル分析 - 抗凝固剤注射の産業チェーン分析 - 抗凝固剤注射の原材料 - 抗凝固剤注射の生産プロセス - 抗凝固剤注射の販売及びマーケティング - 抗凝固剤注射の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 抗凝固剤注射の産業動向 - 抗凝固剤注射のマーケットドライバー - 抗凝固剤注射の課題 - 抗凝固剤注射の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Anticoagulant Injections Market
The global Anticoagulant Injections market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, LMWH accounting for % of the Anticoagulant Injections global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While VTE segment is altered to an % CAGR throughout this forecast period.
China Anticoagulant Injections market size is valued at US$ million in 2021, while the North America and Europe Anticoagulant Injections are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anticoagulant Injections landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anticoagulant Injections market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anticoagulant Injections market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anticoagulant Injections market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anticoagulant Injections market.
Global Anticoagulant Injections Scope and Market Size
Anticoagulant Injections market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Anticoagulant Injections market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
LMWH
Unfractionated Heparin
Fibrinolytics
Other
Segment by Application
VTE
ACS/MI
AF
Other
By Company
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Aspen
Pfizer
Hepalink
King-friend
CSBIO
Amphastar Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulant Injections Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 LMWH
1.2.3 Unfractionated Heparin
1.2.4 Fibrinolytics
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anticoagulant Injections Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulant Injections Market Perspective (2017-2028)
2.2 Anticoagulant Injections Growth Trends by Region
2.2.1 Anticoagulant Injections Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anticoagulant Injections Historic Market Size by Region (2017-2022)
2.2.3 Anticoagulant Injections Forecasted Market Size by Region (2023-2028)
2.3 Anticoagulant Injections Market Dynamics
2.3.1 Anticoagulant Injections Industry Trends
2.3.2 Anticoagulant Injections Market Drivers
2.3.3 Anticoagulant Injections Market Challenges
2.3.4 Anticoagulant Injections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulant Injections Players by Revenue
3.1.1 Global Top Anticoagulant Injections Players by Revenue (2017-2022)
3.1.2 Global Anticoagulant Injections Revenue Market Share by Players (2017-2022)
3.2 Global Anticoagulant Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anticoagulant Injections Revenue
3.4 Global Anticoagulant Injections Market Concentration Ratio
3.4.1 Global Anticoagulant Injections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Injections Revenue in 2021
3.5 Anticoagulant Injections Key Players Head office and Area Served
3.6 Key Players Anticoagulant Injections Product Solution and Service
3.7 Date of Enter into Anticoagulant Injections Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anticoagulant Injections Breakdown Data by Type
4.1 Global Anticoagulant Injections Historic Market Size by Type (2017-2022)
4.2 Global Anticoagulant Injections Forecasted Market Size by Type (2023-2028)
5 Anticoagulant Injections Breakdown Data by Application
5.1 Global Anticoagulant Injections Historic Market Size by Application (2017-2022)
5.2 Global Anticoagulant Injections Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anticoagulant Injections Market Size (2017-2028)
6.2 North America Anticoagulant Injections Market Size by Type
6.2.1 North America Anticoagulant Injections Market Size by Type (2017-2022)
6.2.2 North America Anticoagulant Injections Market Size by Type (2023-2028)
6.2.3 North America Anticoagulant Injections Market Share by Type (2017-2028)
6.3 North America Anticoagulant Injections Market Size by Application
6.3.1 North America Anticoagulant Injections Market Size by Application (2017-2022)
6.3.2 North America Anticoagulant Injections Market Size by Application (2023-2028)
6.3.3 North America Anticoagulant Injections Market Share by Application (2017-2028)
6.4 North America Anticoagulant Injections Market Size by Country
6.4.1 North America Anticoagulant Injections Market Size by Country (2017-2022)
6.4.2 North America Anticoagulant Injections Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anticoagulant Injections Market Size (2017-2028)
7.2 Europe Anticoagulant Injections Market Size by Type
7.2.1 Europe Anticoagulant Injections Market Size by Type (2017-2022)
7.2.2 Europe Anticoagulant Injections Market Size by Type (2023-2028)
7.2.3 Europe Anticoagulant Injections Market Share by Type (2017-2028)
7.3 Europe Anticoagulant Injections Market Size by Application
7.3.1 Europe Anticoagulant Injections Market Size by Application (2017-2022)
7.3.2 Europe Anticoagulant Injections Market Size by Application (2023-2028)
7.3.3 Europe Anticoagulant Injections Market Share by Application (2017-2028)
7.4 Europe Anticoagulant Injections Market Size by Country
7.4.1 Europe Anticoagulant Injections Market Size by Country (2017-2022)
7.4.2 Europe Anticoagulant Injections Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulant Injections Market Size (2017-2028)
8.2 Asia-Pacific Anticoagulant Injections Market Size by Type
8.2.1 Asia-Pacific Anticoagulant Injections Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anticoagulant Injections Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anticoagulant Injections Market Share by Type (2017-2028)
8.3 Asia-Pacific Anticoagulant Injections Market Size by Application
8.3.1 Asia-Pacific Anticoagulant Injections Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anticoagulant Injections Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anticoagulant Injections Market Share by Application (2017-2028)
8.4 Asia-Pacific Anticoagulant Injections Market Size by Region
8.4.1 Asia-Pacific Anticoagulant Injections Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anticoagulant Injections Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anticoagulant Injections Market Size (2017-2028)
9.2 Latin America Anticoagulant Injections Market Size by Type
9.2.1 Latin America Anticoagulant Injections Market Size by Type (2017-2022)
9.2.2 Latin America Anticoagulant Injections Market Size by Type (2023-2028)
9.2.3 Latin America Anticoagulant Injections Market Share by Type (2017-2028)
9.3 Latin America Anticoagulant Injections Market Size by Application
9.3.1 Latin America Anticoagulant Injections Market Size by Application (2017-2022)
9.3.2 Latin America Anticoagulant Injections Market Size by Application (2023-2028)
9.3.3 Latin America Anticoagulant Injections Market Share by Application (2017-2028)
9.4 Latin America Anticoagulant Injections Market Size by Country
9.4.1 Latin America Anticoagulant Injections Market Size by Country (2017-2022)
9.4.2 Latin America Anticoagulant Injections Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulant Injections Market Size (2017-2028)
10.2 Middle East & Africa Anticoagulant Injections Market Size by Type
10.2.1 Middle East & Africa Anticoagulant Injections Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anticoagulant Injections Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anticoagulant Injections Market Share by Type (2017-2028)
10.3 Middle East & Africa Anticoagulant Injections Market Size by Application
10.3.1 Middle East & Africa Anticoagulant Injections Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anticoagulant Injections Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anticoagulant Injections Market Share by Application (2017-2028)
10.4 Middle East & Africa Anticoagulant Injections Market Size by Country
10.4.1 Middle East & Africa Anticoagulant Injections Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anticoagulant Injections Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anticoagulant Injections Introduction
11.1.4 Sanofi Revenue in Anticoagulant Injections Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Details
11.2.2 Genentech (Roche) Business Overview
11.2.3 Genentech (Roche) Anticoagulant Injections Introduction
11.2.4 Genentech (Roche) Revenue in Anticoagulant Injections Business (2017-2022)
11.2.5 Genentech (Roche) Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Anticoagulant Injections Introduction
11.3.4 Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2017-2022)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Aspen
11.4.1 Aspen Company Details
11.4.2 Aspen Business Overview
11.4.3 Aspen Anticoagulant Injections Introduction
11.4.4 Aspen Revenue in Anticoagulant Injections Business (2017-2022)
11.4.5 Aspen Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Anticoagulant Injections Introduction
11.5.4 Pfizer Revenue in Anticoagulant Injections Business (2017-2022)
11.5.5 Pfizer Recent Developments
11.6 Hepalink
11.6.1 Hepalink Company Details
11.6.2 Hepalink Business Overview
11.6.3 Hepalink Anticoagulant Injections Introduction
11.6.4 Hepalink Revenue in Anticoagulant Injections Business (2017-2022)
11.6.5 Hepalink Recent Developments
11.7 King-friend
11.7.1 King-friend Company Details
11.7.2 King-friend Business Overview
11.7.3 King-friend Anticoagulant Injections Introduction
11.7.4 King-friend Revenue in Anticoagulant Injections Business (2017-2022)
11.7.5 King-friend Recent Developments
11.8 CSBIO
11.8.1 CSBIO Company Details
11.8.2 CSBIO Business Overview
11.8.3 CSBIO Anticoagulant Injections Introduction
11.8.4 CSBIO Revenue in Anticoagulant Injections Business (2017-2022)
11.8.5 CSBIO Recent Developments
11.9 Amphastar Pharmaceuticals
11.9.1 Amphastar Pharmaceuticals Company Details
11.9.2 Amphastar Pharmaceuticals Business Overview
11.9.3 Amphastar Pharmaceuticals Anticoagulant Injections Introduction
11.9.4 Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2017-2022)
11.9.5 Amphastar Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Anticoagulant Injections Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of LMWH
Table 3. Key Players of Unfractionated Heparin
Table 4. Key Players of Fibrinolytics
Table 5. Key Players of Other
Table 6. Global Anticoagulant Injections Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Anticoagulant Injections Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Anticoagulant Injections Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Anticoagulant Injections Market Share by Region (2017-2022)
Table 10. Global Anticoagulant Injections Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Anticoagulant Injections Market Share by Region (2023-2028)
Table 12. Anticoagulant Injections Market Trends
Table 13. Anticoagulant Injections Market Drivers
Table 14. Anticoagulant Injections Market Challenges
Table 15. Anticoagulant Injections Market Restraints
Table 16. Global Anticoagulant Injections Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Anticoagulant Injections Revenue Share by Players (2017-2022)
Table 18. Global Top Anticoagulant Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2021)
Table 19. Ranking of Global Top Anticoagulant Injections Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Anticoagulant Injections Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anticoagulant Injections Product Solution and Service
Table 23. Date of Enter into Anticoagulant Injections Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anticoagulant Injections Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Anticoagulant Injections Revenue Market Share by Type (2017-2022)
Table 27. Global Anticoagulant Injections Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Anticoagulant Injections Revenue Market Share by Type (2023-2028)
Table 29. Global Anticoagulant Injections Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Anticoagulant Injections Revenue Share by Application (2017-2022)
Table 31. Global Anticoagulant Injections Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Anticoagulant Injections Revenue Share by Application (2023-2028)
Table 33. North America Anticoagulant Injections Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Anticoagulant Injections Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Anticoagulant Injections Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Anticoagulant Injections Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Anticoagulant Injections Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Anticoagulant Injections Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Anticoagulant Injections Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Anticoagulant Injections Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Anticoagulant Injections Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Anticoagulant Injections Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Anticoagulant Injections Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Anticoagulant Injections Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Anticoagulant Injections Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Anticoagulant Injections Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Anticoagulant Injections Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Anticoagulant Injections Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Anticoagulant Injections Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Anticoagulant Injections Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Anticoagulant Injections Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Anticoagulant Injections Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Anticoagulant Injections Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Anticoagulant Injections Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Anticoagulant Injections Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Anticoagulant Injections Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Anticoagulant Injections Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Anticoagulant Injections Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Anticoagulant Injections Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Anticoagulant Injections Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Anticoagulant Injections Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Anticoagulant Injections Market Size by Country (2023-2028) & (US$ Million)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Anticoagulant Injections Product
Table 66. Sanofi Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
Table 67. Sanofi Recent Developments
Table 68. Genentech (Roche) Company Details
Table 69. Genentech (Roche) Business Overview
Table 70. Genentech (Roche) Anticoagulant Injections Product
Table 71. Genentech (Roche) Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
Table 72. Genentech (Roche) Recent Developments
Table 73. Boehringer Ingelheim Company Details
Table 74. Boehringer Ingelheim Business Overview
Table 75. Boehringer Ingelheim Anticoagulant Injections Product
Table 76. Boehringer Ingelheim Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
Table 77. Boehringer Ingelheim Recent Developments
Table 78. Aspen Company Details
Table 79. Aspen Business Overview
Table 80. Aspen Anticoagulant Injections Product
Table 81. Aspen Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
Table 82. Aspen Recent Developments
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Anticoagulant Injections Product
Table 86. Pfizer Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
Table 87. Pfizer Recent Developments
Table 88. Hepalink Company Details
Table 89. Hepalink Business Overview
Table 90. Hepalink Anticoagulant Injections Product
Table 91. Hepalink Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
Table 92. Hepalink Recent Developments
Table 93. King-friend Company Details
Table 94. King-friend Business Overview
Table 95. King-friend Anticoagulant Injections Product
Table 96. King-friend Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
Table 97. King-friend Recent Developments
Table 98. CSBIO Company Details
Table 99. CSBIO Business Overview
Table 100. CSBIO Anticoagulant Injections Product
Table 101. CSBIO Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
Table 102. CSBIO Recent Developments
Table 103. Amphastar Pharmaceuticals Company Details
Table 104. Amphastar Pharmaceuticals Business Overview
Table 105. Amphastar Pharmaceuticals Anticoagulant Injections Product
Table 106. Amphastar Pharmaceuticals Revenue in Anticoagulant Injections Business (2017-2022) & (US$ Million)
Table 107. Amphastar Pharmaceuticals Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anticoagulant Injections Market Share by Type: 2021 VS 2028
Figure 2. LMWH Features
Figure 3. Unfractionated Heparin Features
Figure 4. Fibrinolytics Features
Figure 5. Other Features
Figure 6. Global Anticoagulant Injections Market Share by Application: 2021 VS 2028
Figure 7. VTE Case Studies
Figure 8. ACS/MI Case Studies
Figure 9. AF Case Studies
Figure 10. Other Case Studies
Figure 11. Anticoagulant Injections Report Years Considered
Figure 12. Global Anticoagulant Injections Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Anticoagulant Injections Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anticoagulant Injections Market Share by Region: 2021 VS 2028
Figure 15. Global Anticoagulant Injections Market Share by Players in 2021
Figure 16. Global Top Anticoagulant Injections Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulant Injections as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Anticoagulant Injections Revenue in 2021
Figure 18. North America Anticoagulant Injections Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Anticoagulant Injections Market Size Market Share by Type (2017-2028)
Figure 20. North America Anticoagulant Injections Market Size Market Share by Application (2017-2028)
Figure 21. North America Anticoagulant Injections Market Size Share by Country (2017-2028)
Figure 22. United States Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Anticoagulant Injections Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Anticoagulant Injections Market Size Market Share by Type (2017-2028)
Figure 26. Europe Anticoagulant Injections Market Size Market Share by Application (2017-2028)
Figure 27. Europe Anticoagulant Injections Market Size Share by Country (2017-2028)
Figure 28. Germany Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Anticoagulant Injections Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Anticoagulant Injections Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Anticoagulant Injections Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Anticoagulant Injections Market Size Share by Region (2017-2028)
Figure 38. China Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Anticoagulant Injections Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Anticoagulant Injections Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Anticoagulant Injections Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Anticoagulant Injections Market Size Share by Country (2017-2028)
Figure 48. Mexico Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Anticoagulant Injections Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Anticoagulant Injections Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Anticoagulant Injections Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Anticoagulant Injections Market Size Share by Country (2017-2028)
Figure 54. Turkey Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Anticoagulant Injections Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
Figure 58. Genentech (Roche) Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
Figure 60. Aspen Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
Figure 61. Pfizer Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
Figure 62. Hepalink Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
Figure 63. King-friend Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
Figure 64. CSBIO Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
Figure 65. Amphastar Pharmaceuticals Revenue Growth Rate in Anticoagulant Injections Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---